{
    "title": "Israel's Teva buys Allergan generic drug company for $40.5B",
    "url": "https://www.dailymail.co.uk/wires/ap/article-3175857/Israels-Teva-buys-Allergan-generic-drug-company-40-5B.html",
    "date": "2015-07-27",
    "keywords": [
        "company",
        "acquisition",
        "teva",
        "drug",
        "gmt",
        "july",
        "monday",
        "business",
        "takeover",
        "trading",
        "statement",
        "president",
        "ceo",
        "patent",
        "treatment",
        "press",
        "email",
        "jerusalem",
        "ap",
        "ltd",
        "largestever",
        "deal",
        "cash",
        "light",
        "offer",
        "nvword",
        "percent",
        "tel",
        "stock",
        "exchange",
        "news",
        "salethe",
        "giant",
        "drugmaker",
        "access",
        "foundation",
        "growth",
        "worldclass",
        "latestage",
        "pipeline",
        "ability",
        "portfolio",
        "specialty",
        "intersection",
        "vigodman",
        "statementbrent",
        "allergan",
        "sale",
        "positionteva",
        "source",
        "pride",
        "israelis",
        "importer",
        "companys",
        "eli",
        "hurwitz",
        "award",
        "tevas",
        "expansion",
        "globe",
        "corp",
        "time",
        "position",
        "producer",
        "drugsthe",
        "copaxone",
        "israel",
        "sclerosis",
        "azilect",
        "plc",
        "wwwallergancom"
    ],
    "category": [
        "wires",
        "ap"
    ]
}